Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 1/20 | 0.36 |
| ▸ | CAPN1 | P07384 | 4/20 | 0.36 |
| ▸ | ACE | P12821 | 1/20 | 0.35 |
| ▸ | TRHR | P34981 | 1/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.34 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.34 |
| ▸ | REN | P00797 | 1/20 | 0.34 |
| ▸ | CTSB | P07858 | 1/20 | 0.34 |
| ▸ | CMA1 | P23946 | 1/20 | 0.34 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31406958 | 0.88 | ACE (0.39) | ACETRHRRENCMA1 | |
| SCHEMBL30558195 | 0.86 | OPRM1 (0.43) | OPRM1OPRD1REN | |
| SCHEMBL29575853 | 0.85 | TERT (0.42) | TERTACEREN | |
| SCHEMBL30445980 | 0.84 | CAPN1 (0.41) | CAPN1TRHROPRM1RENCTSB | |
| SCHEMBL30452849 | 0.84 | ACE (0.43) | ACETRHRREN | |
| SCHEMBL31518665 | 0.83 | ACE (0.46) | ACERENCMA1 | |
| SCHEMBL30829334 | 0.82 | CTSC (0.51) | ACETRHROPRM1RENCMA1 | |
| SCHEMBL29765258 | 0.81 | CAPN1 (0.47) | CAPN1ACERENCTSB | |
| SCHEMBL29765105 | 0.81 | CAPN1 (0.47) | CAPN1ACERENCTSB | |
| SCHEMBL29765249 | 0.81 | CAPN1 (0.47) | CAPN1ACERENCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4039710-B1 | ANTI-CD3 ANTIBODIES, ANTI-CD123 ANTIBODIES AND BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO CD3 AND/OR CD123 | SANOFI SA (FR) | 2026-03-25 | — | — | EP | disclosed |